A. Hunter

Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

S M Moghimi, A C Hunter, S. Moghimi, 2000, Trends in biotechnology.

Cationic carriers of genetic material and cell death: a mitochondrial tale.

S. Moghimi, A. C. Hunter, S. Moghimi, 2010, Biochimica et biophysica acta.

Recognition by Macrophages and Liver Cells of Opsonized Phospholipid Vesicles and Phospholipid Headgroups

S. Moein Moghimi, A. Christy Hunter, S. Moghimi, 2004, Pharmaceutical Research.

Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward.

S. Moghimi, A. C. Hunter, P. P. Wibroe, 2012, Advanced drug delivery reviews.

Special Section on Drug Delivery Technologies — Minireview The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses

D. Simberg, A. Yaghmur, S. Moghimi, 2019 .

Polyethylenimine-mediated impairment of mitochondrial membrane potential, respiration and membrane integrity: implications for nucleic acid delivery and gene therapy.

S. Moghimi, L. Parhamifar, A. C. Hunter, 2012, Mitochondrion.

Smart polymers in drug delivery: a biological perspective

S. Moghimi, A. Hunter, Polym. Chem, 2017 .

Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.

S. Moghimi, C. Alving, J. Szebeni, 2004, Biochimica et biophysica acta.